Antiemetics And Antinauseants Market Size Projected To Increase From $8.71 Billion To $10 Billion During The Forecast Period
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Antiemetics And Antinauseants Market Value Expansion And Long-Term Growth Outlook
The market for antiemetics and antinauseants has experienced consistent expansion over recent years. Projections indicate an increase from $8.48 billion in 2025 to $8.72 billion in 2026, reflecting a compound annual growth rate (CAGR) of 2.8%. This historical growth has been driven by factors such as a higher prevalence of cancer, a greater number of surgical interventions, enhanced awareness regarding chemotherapy-related adverse effects, the broadening of hospital and clinic facilities, and improvements in the development of antiemetic medications.
The antiemetics and antinauseants market is projected to experience consistent expansion over the coming years, reaching an estimated value of $10.01 billion by 2030, with a compound annual growth rate (CAGR) of 3.5%. This expected growth during the forecast period is driven by factors such as the rising incidence of motion sickness, an expanding elderly population worldwide, a growing focus on personalized medicine, advancements in innovative drug delivery mechanisms for antiemetics, and the broadened reach of outpatient chemotherapy alongside palliative care services. Key trends shaping this period encompass the development of tailored anti-nausea therapies, the introduction of novel drug delivery systems, the application of combination therapy strategies, an heightened emphasis on supportive care for chemotherapy patients, and an increase in treatments related to motion sickness and travel-induced nausea.
Download A Free Sample Report For Comprehensive Market Insights:
Antiemetics And Antinauseants Market Opportunity Drivers: What Is Creating New Revenue Potential?
The rising incidence of tuberculosis is anticipated to boost the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is a contagious bacterial infection that primarily affects the lungs. Medications designed to prevent or relieve nausea and vomiting are often used to counteract side effects resulting from anti-tuberculosis treatments. For example, in March 2025, the Centers for Disease Control and Prevention, a federal agency in the United States, reported that in 2024, there were 10,347 provisional TB cases nationwide, translating to a rate of 3.0 cases per 100,000 people—an increase of roughly 8% compared to 2023. As a result, the growing prevalence of tuberculosis is expected to drive the antiemetics and antinauseants market forward.
A surge in surgical procedures is set to propel growth within the antiemetics and antinauseants market, driven by a heightened demand for managing postoperative nausea and vomiting. Surgery entails medical interventions where instruments are employed to address injuries, diseases, or health conditions through incisions or repair of internal structures. The increasing frequency of surgeries is largely attributed to a higher prevalence of chronic illnesses requiring operative care. Antiemetic and antinauseant agents are administered during surgeries to minimize or prevent postoperative nausea and vomiting triggered by anesthesia and surgical techniques. In April 2025, the Australian Institute of Health and Welfare, an Australian government organization, noted that public hospitals recorded 778,500 admissions from elective surgery waitlists in 2023–24—a 5.8% increase from the 735,500 admissions in 2022–23. Consequently, the rising volume of surgical procedures is fueling growth in the antiemetics and antinauseants market.
Antiemetics And Antinauseants Market Segment Breakdown: Which Categories Generate The Most Revenue?
The antiemetics and antinauseants market covered in this report is segmented –
1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By Cannabinoids: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices
Antiemetics And Antinauseants Market Innovation Trends Driving Future Development
Major players within the antiemetic and antinauseant sectors are actively advancing product innovations—particularly ready-to-use injectables—designed to simplify treatment protocols and improve patient adherence. These prefilled formulations aim to deliver rapid therapeutic effects while minimizing the time and intricacy usually associated with traditional injectable drugs. To illustrate, in July 2024, the US-based pharmaceutical firm Amneal Pharmaceuticals introduced FOCINVEZ, the inaugural ready-to-use injectable version of fosaprepitant, intended to prevent both immediate and delayed nausea and vomiting triggered by highly emetogenic cancer chemotherapy. Supplied in a 150 mg/50 mL vial that is Polysorbate 80‑free, this product eliminates the need for reconstitution or dilution, enabling direct administration. Approved for adult patients and pediatric individuals aged six months and older, FOCINVEZ has been given a dedicated J‑Code (J1434) for billing and reimbursement purposes.
Antiemetics And Antinauseants Market Key Players And Strategic Industry Positioning
Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA
Access The Complete Antiemetics And Antinauseants Market Report:
Antiemetics And Antinauseants Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
